Related Experiment Videos
Renal transplantation in sickle cell disease
Clinical Nephrology
|October 1, 1982
Summary
Hemodialysis and renal transplantation can be successful for patients with sickle cell disease and end-stage renal failure. Careful management of high hemoglobin S levels is crucial post-transplant.
Area of Science:
- Nephrology
- Hematology
- Transplantation immunology
Background:
- Sickle cell disease (SCD) frequently leads to end-stage renal failure (ESRF).
- Management of ESRF in SCD patients presents unique challenges, including potential complications from the disease itself.
Observation:
- A 49-year-old West Indian male with SCD and ESRF underwent hemodialysis for 10 months.
- He subsequently received a cadaveric renal transplant.
Findings:
- Post-transplant, the patient exhibited good renal function nine months after the procedure.
- Persistent high hemoglobin S (HbS) levels necessitated repeated exchange transfusions, posing a significant clinical challenge.
Implications:
- Hemodialysis and renal transplantation are viable treatment options for SCD patients with ESRF.
- Close monitoring and management of HbS levels are essential for successful long-term outcomes in these patients.